bmiMD review
Struck-through, term-gated
bmiMD shows $99 struck through from $151.20 and labeled a limited-time offer. The $99 is the twelve-month rate; a month at a time is $129.
Our verdict
The strike-through and the countdown framing make the $99 look like a discount on a monthly price. It is a discount on a twelve-month commitment. Month to month, semaglutide is $129 and tirzepatide $179 — still below the middle of this market, just not the number on the page.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- compounded semaglutide
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- Pharmacy
- Not named
- Availability
- 50 states
- Updated
- September 2026
What it is
A telehealth service selling compounded semaglutide and tirzepatide as low-dose weekly injections across fifty states, marketed under a microdose framing.
How it works
Prescription-gated subscription with pricing tiered by commitment length. The strike-through presentation applies to every tier, so the anchor price moves with the plan rather than describing a former price.
Pricing transparency
Semaglutide runs from $99 a month on twelve months up to $129 month to month, anchored against $151.20 to $199.80. Tirzepatide runs $139 to $179, anchored against $250.20 to $299.70. Prices hold across doses.
Branded vs compounded
Compounded semaglutide and tirzepatide, sold in a microdose protocol. Compounded drugs are not FDA-approved or reviewed for safety, efficacy or quality before dispensing, and low-dose protocols sit outside the labeled titration schedules.
Pros and watch-outs
What we like
- Below the market middle even at the month-to-month rate
- Price holds as the dose climbs
- Publishes tiers rather than one gated figure
- Fifty states
Watch-outs
- The headline $99 requires a twelve-month commitment
- Strike-through anchors are not a former price, which the presentation implies
- The limited-time label sits on pricing that appears to be standing
Best for
Buyers committing to a year who want a low flat rate across doses.
Who should look elsewhere
Anyone reading the struck-through figure as the monthly price — it is $30 higher.
How bmiMD compares
A few alternatives worth a look, depending on what you’re optimizing for.
- SkinnyRx
A tirzepatide price you can check
See SkinnyRx → - Shed
Compounded pricing without a membership
See Shed → - RxSpan MD
Comparing plan terms upfront
See RxSpan MD →
More compounded semaglutide sellers reviews: altRXAlways Wellness and RecoveryAlyveRxAM RxAmazon One MedicalAmble
Pricing & provider data · Last updated September 2026
How we assessed this. This review reflects GLP Loss’s own read of bmiMD’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Is bmiMD really $99 a month?
- On a twelve-month plan, yes. Paying month to month it is $129 for semaglutide. The struck-through $151.20 beside the $99 is an anchor rather than a price bmiMD previously charged.
- What is a GLP-1 microdose?
- A protocol using doses below the standard titration schedule. It is off-label, and the evidence base for it is much thinner than for the labeled doses. Whether it suits you is a clinical question rather than a pricing one.
- Does bmiMD charge more at higher doses?
- No. The monthly figure holds across dosages; what moves the price is the length of the plan you choose.
- Is the limited-time offer genuine?
- The pricing has been presented that way consistently. Treat the tier structure as the real pricing and the countdown framing as marketing, and compare the month-to-month figure against other sellers' monthly rates.
- Is bmiMD legit?
- bmiMD is a GLP-1 telehealth service. Its stated availability: 50 states. Before you pay, confirm whether it bills insurance and how its intake works in writing for your selected treatment.
- Is bmiMD expensive compared with other GLP-1 providers?
- bmiMD is listed from $99/mo in this comparison. The 387 reviewed GLP-1 providers with a listed monthly starting amount range from $76 to $1299, with a median of $179. That puts bmiMD below the median. The comparison excludes 192 other reviewed GLP-1 providers. Medicines, doses and payment commitments differ. Confirm the medication, renewal charge and included visits, supplies and delivery before deciding.